Evotec SE (EVO) Amortization - Intangibles (2009 - 2023)
Evotec SE's (EVO) quarterly Amortization - Intangibles came in at $4.2 million in Q3 2023, up 85129.55% quarter-over-quarter from $4983.9 in Q4 2022.
Analysis
Evotec SE (EVO) Amortization - Intangibles (2009 - 2023) Analysis & Trends
Evotec SE has disclosed Amortization - Intangibles across 3 years of filings, most recently posting $4.2 million for Q3 2023.
- In Q3 2023, Amortization - Intangibles changed N/A year-over-year to $4.2 million; the TTM figure through Aug 2023 stood at $4.5 million (changed N/A YoY), while the FY2022 annual figure was $5148.6, changed N/A from the prior year.
- Amortization - Intangibles came in at $4.2 million for Q3 2023 at Evotec SE, up from $4983.9 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $4.2 million in Q3 2023 to a low of $4983.9 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 29, 2023 | 4.25 Mn |
| Dec 31, 2022 | 4,983.91 |
| Jun 30, 2009 | 140,249.78 |
| Mar 31, 2009 | 102,003.22 |